Crocetin Alleviates Inflammation in MPTP-Induced Parkinson’s Disease Models through Improving Mitochondrial Functions
Parkinson's Disease · 10.10.2020 · 2020 · 1-9
DOI: 10.1155/2020/9864370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parkinson's Disease, erschienen am 10.10.2020. Verfasst von Na Dong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nantong Science and Technology Bureau.
Abstract (Originalsprache)
Parkinson’s disease (PD) is the second most common neurodegenerative disease. Crocetin, derived from saffron, exerts multiple pharmacological properties, such as anti-inflammatory, antioxidant, antifatigue, and anticancer effects. However, the effect of crocetin on PD remains unclear. In this study, we designed experiments to investigate the effect of crocetin against MPTP-induced PD models and the underlying mechanisms. Our results showed that crocetin treatment attenuates MPTP-induced motor deficits and protects dopaminergic neurons. Both in vivo and in vitro experiments demonstrated that crocetin treatment decreased the expression of inflammatory associated genes and inflammatory cytokines. Furthermore, crocetin treatment protected mitochondrial functions against MPP+ induced damage by regulating the mPTP ( mitochondrial permeability transition pore ) viability in the interaction of ANT ( adenine nucleotide translocase ) and Cyp D ( Cyclophilin D ) dependent manner. Therefore, our results demonstrate that crocetin has therapeutic potential in Parkinson’s disease.
Autor:innen und Institutionen
- Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China.
- Department of Neurology, Affliated Hospital of Nantong University, Nantong, Jiangsu 226001, China.
ORCID-Profile: Xiaosu Gu
Förderung
- Nantong Science and Technology Bureau
Zitieren
APA
Dong, N., Dong, Z., Chen, Y., & Gu, X. (2020). Crocetin Alleviates Inflammation in MPTP-Induced Parkinson’s Disease Models through Improving Mitochondrial Functions. Parkinson's Disease, 2020, 1-9. https://doi.org/10.1155/2020/9864370
Vancouver
Dong N, Dong Z, Chen Y, Gu X. Crocetin Alleviates Inflammation in MPTP-Induced Parkinson’s Disease Models through Improving Mitochondrial Functions. Parkinson's Disease. 2020;2020:1-9. doi:10.1155/2020/9864370
BibTeX
@article{Dong2020,
author = {Dong, Na and Dong, Zhong and Chen, Ying and Gu, Xiaosu},
title = {Crocetin Alleviates Inflammation in MPTP-Induced Parkinson’s Disease Models through Improving Mitochondrial Functions},
journal = {Parkinson's Disease},
year = {2020},
volume = {2020},
pages = {1--9},
doi = {10.1155/2020/9864370}
}
EUVIMED